Trial 13NHL-16-3


PhI-79 A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients with Relapsed or Refractory Non-Hodgkins Lymphoma (NHL)

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments:
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Mojtaba Akhtari, M.D.
Other Trial Staff:  Simbiso Peresuh, Coordinator, John Lee, D.M., Suraj Chandwani, D.M., Madelyn Lefler, R.N., Anastasia Philabaum, R.N., Christine Duran, Coordinator, Ibrahim Syed, Coordinator, Donna Fernando, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.